DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Treatment Sequencing: Oncology

Analyze sequential, line-by-line treatment pathways in market-relevant scenarios to support brand positioning, strategic planning, and business development

  • Understand the treatment journey and drug positioning across highly dynamic oncology indications
  • Evaluate treatment rates and a therapy’s position and share within specific commercially relevant patient populations
  • Discover where your drug – or a competitor’s – falls in the most popular treatment sequences, and devise a strategy to improve your positioning

 

Schedule a demo

“With the influx of new clinical developments and combination therapies, physicians are often faced with difficult choices on what and when to prescribe. As a result, pharma strategists are often navigating positioning decisions without a map.”

Rachel Webster

Principal Director, Oncology

Methodology

  • Primary market research with 100 U.S. and 250 EU5 physician specialists
  • DRG’s specialist-based quantitative drug sequencing analysis